1 Ibrutinib API Market Overview 1.1 Product Overview and Scope of Ibrutinib API 1.2 Ibrutinib API Segment by Type 1.2.1 Global Ibrutinib API Market Size Growth Rate Analysis by Type 2021 VS 2027 1.2.2 Purity≥98% 1.2.3 Purity<98% 1.3 Ibrutinib API Segment by Application 1.3.1 Global Ibrutinib API Consumption Comparison by Application: 2016 VS 2021 VS 2027 1.3.2 Ibrutinib Capsules 1.3.3 Others 1.4 Global Market Growth Prospects 1.4.1 Global Ibrutinib API Revenue Estimates and Forecasts (2016-2027) 1.4.2 Global Ibrutinib API Production Capacity Estimates and Forecasts (2016-2027) 1.4.3 Global Ibrutinib API Production Estimates and Forecasts (2016-2027) 1.5 Global Market Size by Region 1.5.1 Global Ibrutinib API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027 1.5.2 India Ibrutinib API Estimates and Forecasts (2016-2027) 1.5.3 Israel Ibrutinib API Estimates and Forecasts (2016-2027) 1.5.4 China Ibrutinib API Estimates and Forecasts (2016-2027) 2 Market Competition by Manufacturers 2.1 Global Ibrutinib API Production Capacity Market Share by Manufacturers (2016-2021) 2.2 Global Ibrutinib API Revenue Market Share by Manufacturers (2016-2021) 2.3 Ibrutinib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.4 Global Ibrutinib API Average Price by Manufacturers (2016-2021) 2.5 Manufacturers Ibrutinib API Production Sites, Area Served, Product Types 2.6 Ibrutinib API Market Competitive Situation and Trends 2.6.1 Ibrutinib API Market Concentration Rate 2.6.2 Global 5 and 10 Largest Ibrutinib API Players Market Share by Revenue 2.6.3 Mergers & Acquisitions, Expansion 3 Production and Capacity by Region 3.1 Global Production Capacity of Ibrutinib API Market Share by Region (2016-2021) 3.2 Global Ibrutinib API Revenue Market Share by Region (2016-2021) 3.3 Global Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 India Ibrutinib API Production 3.4.1 India Ibrutinib API Production Growth Rate (2016-2021) 3.4.2 India Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Israel Ibrutinib API Production 3.5.1 Israel Ibrutinib API Production Growth Rate (2016-2021) 3.5.2 Israel Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 China Ibrutinib API Production 3.6.1 China Ibrutinib API Production Growth Rate (2016-2021) 3.6.2 China Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Ibrutinib API Consumption by Region 4.1 Global Ibrutinib API Consumption by Region 4.1.1 Global Ibrutinib API Consumption by Region 4.1.2 Global Ibrutinib API Consumption Market Share by Region 4.2 North America 4.2.1 North America Ibrutinib API Consumption by Country 4.2.2 United States 4.2.3 Canada 4.3 Europe 4.3.1 Europe Ibrutinib API Consumption by Country 4.3.2 Germany 4.3.3 France 4.3.4 U.K. 4.3.5 Italy 4.3.6 Russia 4.4 Asia Pacific 4.4.1 Asia Pacific Ibrutinib API Consumption by Region 4.4.2 China 4.4.3 Japan 4.4.4 South Korea 4.4.5 Taiwan 4.4.6 Southeast Asia 4.4.7 India 4.4.8 Australia 4.5 Latin America 4.5.1 Latin America Ibrutinib API Consumption by Country 4.5.2 Mexico 4.5.3 Brazil 5 Production, Revenue, Price Trend by Type 5.1 Global Ibrutinib API Production Market Share by Type (2016-2021) 5.2 Global Ibrutinib API Revenue Market Share by Type (2016-2021) 5.3 Global Ibrutinib API Price by Type (2016-2021) 6 Consumption Analysis by Application 6.1 Global Ibrutinib API Consumption Market Share by Application (2016-2021) 6.2 Global Ibrutinib API Consumption Growth Rate by Application (2016-2021) 7 Key Companies Profiled 7.1 Dr. Reddy’s Laboratories Ltd. 7.1.1 Dr. Reddy’s Laboratories Ltd. Ibrutinib API Corporation Information 7.1.2 Dr. Reddy’s Laboratories Ltd. Ibrutinib API Product Portfolio 7.1.3 Dr. Reddy’s Laboratories Ltd. Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served 7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates 7.2 Teva API 7.2.1 Teva API Ibrutinib API Corporation Information 7.2.2 Teva API Ibrutinib API Product Portfolio 7.2.3 Teva API Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.2.4 Teva API Main Business and Markets Served 7.2.5 Teva API Recent Developments/Updates 7.3 Shilpa Medicare Limited 7.3.1 Shilpa Medicare Limited Ibrutinib API Corporation Information 7.3.2 Shilpa Medicare Limited Ibrutinib API Product Portfolio 7.3.3 Shilpa Medicare Limited Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.3.4 Shilpa Medicare Limited Main Business and Markets Served 7.3.5 Shilpa Medicare Limited Recent Developments/Updates 7.4 Wisdom Pharmaceutical Co., Ltd. 7.4.1 Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Corporation Information 7.4.2 Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Product Portfolio 7.4.3 Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.4.4 Wisdom Pharmaceutical Co., Ltd. Main Business and Markets Served 7.4.5 Wisdom Pharmaceutical Co., Ltd. Recent Developments/Updates 7.5 ScinoPharm Taiwan, Ltd 7.5.1 ScinoPharm Taiwan, Ltd Ibrutinib API Corporation Information 7.5.2 ScinoPharm Taiwan, Ltd Ibrutinib API Product Portfolio 7.5.3 ScinoPharm Taiwan, Ltd Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.5.4 ScinoPharm Taiwan, Ltd Main Business and Markets Served 7.5.5 ScinoPharm Taiwan, Ltd Recent Developments/Updates 7.6 Sun Pharmaceutical Industries Ltd. 7.6.1 Sun Pharmaceutical Industries Ltd. Ibrutinib API Corporation Information 7.6.2 Sun Pharmaceutical Industries Ltd. Ibrutinib API Product Portfolio 7.6.3 Sun Pharmaceutical Industries Ltd. Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served 7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates 7.7 Haoyuan Chemexpress 7.7.1 Haoyuan Chemexpress Ibrutinib API Corporation Information 7.7.2 Haoyuan Chemexpress Ibrutinib API Product Portfolio 7.7.3 Haoyuan Chemexpress Ibrutinib API Production Capacity, Revenue, Price and Gross Margin (2016-2021) 7.7.4 Haoyuan Chemexpress Main Business and Markets Served 7.7.5 Haoyuan Chemexpress Recent Developments/Updates 8 Ibrutinib API Manufacturing Cost Analysis 8.1 Ibrutinib API Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Key Raw Materials Price Trend 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Ibrutinib API 8.4 Ibrutinib API Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel 9.2 Ibrutinib API Distributors List 9.3 Ibrutinib API Customers 10 Market Dynamics 10.1 Ibrutinib API Industry Trends 10.2 Ibrutinib API Growth Drivers 10.3 Ibrutinib API Market Challenges 10.4 Ibrutinib API Market Restraints 11 Production and Supply Forecast 11.1 Global Forecasted Production of Ibrutinib API by Region (2022-2027) 11.2 India Ibrutinib API Production, Revenue Forecast (2022-2027) 11.3 Israel Ibrutinib API Production, Revenue Forecast (2022-2027) 11.4 China Ibrutinib API Production, Revenue Forecast (2022-2027) 12 Consumption and Demand Forecast 12.1 Global Forecasted Demand Analysis of Ibrutinib API 12.2 North America Forecasted Consumption of Ibrutinib API by Country 12.3 Europe Market Forecasted Consumption of Ibrutinib API by Country 12.4 Asia Pacific Market Forecasted Consumption of Ibrutinib API by Region 12.5 Latin America Forecasted Consumption of Ibrutinib API by Country 13 Forecast by Type and by Application (2022-2027) 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027) 13.1.1 Global Forecasted Production of Ibrutinib API by Type (2022-2027) 13.1.2 Global Forecasted Revenue of Ibrutinib API by Type (2022-2027) 13.1.3 Global Forecasted Price of Ibrutinib API by Type (2022-2027) 13.2 Global Forecasted Consumption of Ibrutinib API by Application (2022-2027) 14 Research Finding and Conclusion 15 Methodology and Data Source 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Author List 15.4 Disclaimer

List of Tables Table 1. Global Ibrutinib API Market Size by Type (Ton) & (US$ Million) (2021 VS 2027) Table 2. Global Ibrutinib API Consumption (Ton) Comparison by Application: 2016 VS 2021 VS 2027 Table 3. Ibrutinib API Market Size Comparison by Region: 2016 VS 2021 VS 2027 Table 4. Global Ibrutinib API Production Capacity (Ton) by Manufacturers Table 5. Global Ibrutinib API Production (Ton) by Manufacturers (2016-2021) Table 6. Global Ibrutinib API Production Market Share by Manufacturers (2016-2021) Table 7. Global Ibrutinib API Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Ibrutinib API Revenue Share by Manufacturers (2016-2021) Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ibrutinib API as of 2020) Table 10. Global Market Ibrutinib API Average Price (US$/Ton) of Key Manufacturers (2016-2021) Table 11. Manufacturers Ibrutinib API Production Sites and Area Served Table 12. Manufacturers Ibrutinib API Product Types Table 13. Mergers & Acquisitions, Expansion Table 14. Global Ibrutinib API Production Capacity (Ton) by Region (2016-2021) Table 15. Global Ibrutinib API Production (Ton) by Region (2016-2021) Table 16. Global Ibrutinib API Revenue (US$ Million) by Region (2016-2021) Table 17. Global Ibrutinib API Revenue Market Share by Region (2016-2021) Table 18. Global Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 19. India Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 20. Israel Ibrutinib API Production (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 21. China Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 22. Global Ibrutinib API Consumption Market by Region (2016-2021) & (Ton) Table 23. Global Ibrutinib API Consumption Market Share by Region (2016-2021) Table 24. North America Ibrutinib API Consumption by Country (2016-2021) & (Ton) Table 25. Europe Ibrutinib API Consumption by Country (2016-2021) & (Ton) Table 26. Asia Pacific Ibrutinib API Consumption by Region (2016-2021) & (Ton) Table 27. Latin America Ibrutinib API Consumption by Countries (2016-2021) & (Ton) Table 28. Global Ibrutinib API Production (Ton) by Type (2016-2021) Table 29. Global Ibrutinib API Production Market Share by Type (2016-2021) Table 30. Global Ibrutinib API Revenue (US$ Million) by Type (2016-2021) Table 31. Global Ibrutinib API Revenue Share by Type (2016-2021) Table 32. Global Ibrutinib API Price (US$/Ton) by Type (2016-2021) Table 33. Global Ibrutinib API Consumption by Application (2016-2021) & (Ton) Table 34. Global Ibrutinib API Consumption Market Share by Application (2016-2021) Table 35. Global Ibrutinib API Consumption Growth Rate by Application (2016-2021) Table 36. Dr. Reddy’s Laboratories Ltd. Ibrutinib API Corporation Information Table 37. Dr. Reddy’s Laboratories Ltd. Specification and Application Table 38. Dr. Reddy’s Laboratories Ltd. Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 39. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served Table 40. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates Table 41. Teva API Ibrutinib API Corporation Information Table 42. Teva API Specification and Application Table 43. Teva API Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 44. Teva API Main Business and Markets Served Table 45. Teva API Recent Developments/Updates Table 46. Shilpa Medicare Limited Ibrutinib API Corporation Information Table 47. Shilpa Medicare Limited Specification and Application Table 48. Shilpa Medicare Limited Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 49. Shilpa Medicare Limited Main Business and Markets Served Table 50. Shilpa Medicare Limited Recent Developments/Updates Table 51. Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Corporation Information Table 52. Wisdom Pharmaceutical Co., Ltd. Specification and Application Table 53. Wisdom Pharmaceutical Co., Ltd. Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 54. Wisdom Pharmaceutical Co., Ltd. Main Business and Markets Served Table 55. Wisdom Pharmaceutical Co., Ltd. Recent Developments/Updates Table 56. ScinoPharm Taiwan, Ltd Ibrutinib API Corporation Information Table 57. ScinoPharm Taiwan, Ltd Specification and Application Table 58. ScinoPharm Taiwan, Ltd Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 59. ScinoPharm Taiwan, Ltd Main Business and Markets Served Table 60. ScinoPharm Taiwan, Ltd Recent Developments/Updates Table 61. Sun Pharmaceutical Industries Ltd. Ibrutinib API Corporation Information Table 62. Sun Pharmaceutical Industries Ltd. Specification and Application Table 63. Sun Pharmaceutical Industries Ltd. Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 64. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served Table 65. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates Table 66. Haoyuan Chemexpress Ibrutinib API Corporation Information Table 67. Haoyuan Chemexpress Specification and Application Table 68. Haoyuan Chemexpress Ibrutinib API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 69. Haoyuan Chemexpress Main Business and Markets Served Table 70. Haoyuan Chemexpress Recent Developments/Updates Table 71. Production Base and Market Concentration Rate of Raw Material Table 72. Key Suppliers of Raw Materials Table 73. Ibrutinib API Distributors List Table 74. Ibrutinib API Customers List Table 75. Ibrutinib API Market Trends Table 76. Ibrutinib API Growth Drivers Table 77. Ibrutinib API Market Challenges Table 78. Ibrutinib API Market Restraints Table 79. Global Ibrutinib API Production (Ton) Forecast by Region (2022-2027) Table 80. North America Ibrutinib API Consumption Forecast by Country (2022-2027) & (Ton) Table 81. Europe Ibrutinib API Consumption Forecast by Country (2022-2027) & (Ton) Table 82. Asia Pacific Ibrutinib API Consumption Forecast by Region (2022-2027) & (Ton) Table 83. Latin America Ibrutinib API Consumption Forecast by Country (2022-2027) & (Ton) Table 84. Global Ibrutinib API Production Forecast by Type (2022-2027) & (Ton) Table 85. Global Ibrutinib API Revenue Forecast by Type (2022-2027) & (US$ Million) Table 86. Global Ibrutinib API Price Forecast by Type (2022-2027) & (US$/Ton) Table 87. Global Ibrutinib API Consumption (Ton) Forecast by Application (2022-2027) Table 88. Research Programs/Design for This Report Table 89. Key Data Information from Secondary Sources Table 90. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ibrutinib API Figure 2. Global Ibrutinib API Market Share by Type: 2020 VS 2027 Figure 3. Purity≥98% Product Picture Figure 4. Purity<98% Product Picture Figure 5. Global Ibrutinib API Market Share by Application: 2020 VS 2027 Figure 6. Ibrutinib Capsules Figure 7. Others Figure 8. Global Ibrutinib API Revenue (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Ibrutinib API Revenue (US$ Million) (2016-2027) Figure 10. Global Ibrutinib API Production Capacity (Ton) & (2016-2027) Figure 11. Global Ibrutinib API Production (Ton) & (2016-2027) Figure 12. India Ibrutinib API Revenue (US$ Million) and Growth Rate (2016-2027) Figure 13. Israel Ibrutinib API Revenue (US$ Million) and Growth Rate (2016-2027) Figure 14. China Ibrutinib API Revenue (US$ Million) and Growth Rate (2016-2027) Figure 15. Ibrutinib API Production Share by Manufacturers in 2020 Figure 16. Global Ibrutinib API Revenue Share by Manufacturers in 2020 Figure 17. Ibrutinib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 18. Global Market Ibrutinib API Average Price (US$/Ton) of Key Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Players: Market Share by Ibrutinib API Revenue in 2020 Figure 20. Global Ibrutinib API Production Market Share by Region (2016-2021) Figure 21. India Ibrutinib API Production (Ton) Growth Rate (2016-2021) Figure 22. Israel Ibrutinib API Production (Ton) Growth Rate (2016-2021) Figure 23. China Ibrutinib API Production (Ton) Growth Rate (2016-2021) Figure 24. Global Ibrutinib API Consumption Market Share by Region (2016-2021) Figure 25. Global Ibrutinib API Consumption Market Share by Region in 2020 Figure 26. North America Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 27. North America Ibrutinib API Consumption Market Share by Country in 2020 Figure 28. Canada Ibrutinib API Consumption Growth Rate (2016-2021) & (Ton) Figure 29. U.S. Ibrutinib API Consumption Growth Rate (2016-2021) & (Ton) Figure 30. Europe Ibrutinib API Consumption Growth Rate (2016-2021) & (Ton) Figure 31. Europe Ibrutinib API Consumption Market Share by Country in 2020 Figure 32. Germany America Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 33. France Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 34. U.K. Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 35. Italy Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 36. Russia Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 37. Asia Pacific Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 38. Asia Pacific Ibrutinib API Consumption Market Share by Regions in 2020 Figure 39. China Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 40. Japan Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 41. South Korea Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 42. Taiwan Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 43. Southeast Asia Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 44. India Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 45. Australia Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 46. Latin America Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 47. Latin America Ibrutinib API Consumption Market Share by Country in 2020 Figure 48. Mexico Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 49. Brazil Ibrutinib API Consumption and Growth Rate (2016-2021) & (Ton) Figure 50. Production Market Share of Ibrutinib API by Type (2016-2021) Figure 51. Production Market Share of Ibrutinib API by Type in 2020 Figure 52. Revenue Share of Ibrutinib API by Type (2016-2021) Figure 53. Revenue Market Share of Ibrutinib API by Type in 2020 Figure 54. Global Ibrutinib API Consumption Market Share by Application (2016-2021) Figure 55. Global Ibrutinib API Consumption Market Share by Application in 2020 Figure 56. Global Ibrutinib API Consumption Growth Rate by Application (2016-2021) Figure 57. Key Raw Materials Price Trend Figure 58. Manufacturing Cost Structure of Ibrutinib API Figure 59. Manufacturing Process Analysis of Ibrutinib API Figure 60. Ibrutinib API Industrial Chain Analysis Figure 61. Channels of Distribution Figure 62. Distributors Profiles Figure 63. Global Ibrutinib API Production Market Share Forecast by Region (2022-2027) Figure 64. India Ibrutinib API Production (Ton) Growth Rate Forecast (2022-2027) Figure 65. Israel Ibrutinib API Production (Ton) Growth Rate Forecast (2022-2027) Figure 66. China Ibrutinib API Production (Ton) Growth Rate Forecast (2022-2027) Figure 67. Global Forecasted Demand Analysis of Ibrutinib API (2015-2027) & (Ton) Figure 68. Global Ibrutinib API Production Market Share Forecast by Type (2022-2027) Figure 69. Global Ibrutinib API Revenue Market Share Forecast by Type (2022-2027) Figure 70. Global Ibrutinib API Consumption Forecast by Application (2022-2027) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation

Dr. Reddy’s Laboratories Ltd. Teva API Shilpa Medicare Limited Wisdom Pharmaceutical Co., Ltd. ScinoPharm Taiwan, Ltd Sun Pharmaceutical Industries Ltd. Haoyuan Chemexpress